Global Eicosanedioic Acid Market Outlook 2025: Suppliers, Prices, Pharma-Grade Applications

Description

Overview
Eicosanedioic Acid (CAS 505-57-7) is an increasingly critical intermediate in the formulation of long-acting therapeutic peptides. Its role in enhancing drug stability, dosing intervals, and patient compliance has driven demand across pharmaceutical pipelines globally. This report provides a comprehensive view of the market size, pricing trends, trade dynamics, and manufacturer benchmarking for ≥98% purity grades of C₂₀ dicarboxylic acid used in regulated pharmaceutical formulations.

What’s Driving Demand Now
Recent market data confirms a 24 crore INR sales figure in just three months for a newly launched metabolic peptide drug in India, with dose escalation trends indicating longer treatment cycles and higher intermediate consumption.

A reported 7.1x increase in 12.5 mg dose uptake points toward strong patient response and therapeutic adoption.

Hospitals across major metros are incorporating this molecule into core metabolic disease treatment protocols, further validating downstream demand.

Producers with Export-Ready Capacity

Shanghai Synchem Technology Co., Ltd., China (Large-scale pharma-grade supply)
Changzhou Kechem Bio-Scientific Co., Ltd., China (Controlled impurity production)
Shandong Juntai Pharmaceutical Co., Ltd., China (Regulated market exports)
Sichuan HongRi Pharma-Tech Co., Ltd., China (Custom synthesis, stability focus)
Hebei Chuanghai Biotechnology Co., Ltd., China (High-purity and real-time pricing)
XIAMEN Sinopeg Biotech Co., Ltd., China (Lipidation intermediates specialist)
Sinochem Qingdao, China (Fine chemicals and custom projects)

Included in the Report

Market Size & Forecast (2020–2030), broken down by application
Trade Flow Analysis: Asia-dominant supply and global dependency mapping
Gross Margin Breakdown: From $1.8/kg feedstock to $9/kg final grade
Key Use Case Expansion: Neurodegenerative, metabolic, and cardiovascular indications
Technology Trends: Lipidation chemistry innovations and process optimization
Strategic Recommendations for sourcing teams, CDMOs, and specialty chemical investors

Use This Report To

Benchmark sourcing options for peptide lipidation intermediates
Evaluate pricing trends and supply bottlenecks
Map competitive advantages in API-grade C₂₀ diacid production
Identify near-term opportunities linked to evolving therapeutic markets